Cargando…

A Molecularly Characterized Preclinical Platform of Subcutaneous Renal Cell Carcinoma (RCC) Patient-Derived Xenograft Models to Evaluate Novel Treatment Strategies

Renal cell carcinoma (RCC) is a kidney cancer with an onset mainly during the sixth or seventh decade of the patient’s life. Patients with advanced, metastasized RCC have a poor prognosis. The majority of patients develop treatment resistance towards Standard of Care (SoC) drugs within months. Tyros...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gürgen, Dennis, Becker, Michael, Dahlmann, Mathias, Flechsig, Susanne, Schaeffeler, Elke, Büttner, Florian A., Schmees, Christian, Bohnert, Regina, Bedke, Jens, Schwab, Matthias, Wendler, Johann J., Schostak, Martin, Jandrig, Burkhard, Walther, Wolfgang, Hoffmann, Jens
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254864/ https://www.ncbi.nlm.nih.gov/pubmed/35800063 http://dx.doi.org/10.3389/fonc.2022.889789

Ejemplares similares

Thioredoxin 1 (Trx1) is associated with poor prognosis in clear cell renal cell carcinoma (ccRCC): an example for the crucial role of redox signaling in ccRCC
por: Ribback, Silvia, et al.
Publicado: (2021)

Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy
por: Reustle, Anna, et al.
Publicado: (2020)

Autoantibodies directed against α1-adrenergic receptor and endothelin receptor A in patients with prostate cancer
por: Wallukat, Gerd, et al.
Publicado: (2020)

The Non-Interventional PAZOREAL Study to Assess the Effectiveness and Safety of Pazopanib in a Real-Life Setting: Reflecting a Changing mRCC Treatment Landscape
por: Doehn, Christian, et al.
Publicado: (2022)

Hypertonicity-Affected Genes Are Differentially Expressed in Clear Cell Renal Cell Carcinoma and Correlate with Cancer-Specific Survival
por: Kandabarau, Siarhei, et al.
Publicado: (2019)

Nicotinamide‐N‐methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma
por: Reustle, Anna, et al.
Publicado: (2022)

Characterization of Genetic Heterogeneity in Recurrent Metastases of Renal Cell Carcinoma
por: Sauter-Meyerhoff, Carolin, et al.
Publicado: (2021)

Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma
por: Büttner, Florian, et al.
Publicado: (2018)

Inhibition of angiogenic and non-angiogenic targets by sorafenib in renal cell carcinoma (RCC) in a RCC xenograft model
por: Yuen, J S P, et al.
Publicado: (2011)

MCT4 surpasses the prognostic relevance of the ancillary protein CD147 in clear cell renal cell carcinoma
por: Fisel, Pascale, et al.
Publicado: (2015)

p53 is functionally inhibited in clear cell renal cell carcinoma (ccRCC): a mechanistic and correlative investigation into genetic and molecular characteristics
por: Diesing, Karoline, et al.
Publicado: (2021)

Pharmacogenomics: a key component of personalized therapy
por: Schwab, Matthias, et al.
Publicado: (2012)

Breaking the crosstalk of the Cellular Tumorigenic Network by low-dose combination therapy in lung cancer patient-derived xenografts
por: Gürgen, Dennis, et al.
Publicado: (2022)

Functional and mutational analysis after radiation and cetuximab treatment on prostate carcinoma cell line DU145
por: Schneider, Raik, et al.
Publicado: (2021)

Clinical and Functional Relevance of the Monocarboxylate Transporter Family in Disease Pathophysiology and Drug Therapy
por: Fisel, Pascale, et al.
Publicado: (2018)

Crosstalk between Akt signaling and cold shock proteins in mediating invasive cell phenotypes
por: Hohlfeld, Raphael, et al.
Publicado: (2018)

Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenes
por: Winter, Stefan, et al.
Publicado: (2016)

Irreversible Electroporation (IRE): Standardization of Terminology and Reporting Criteria for Analysis and Comparison
por: Wendler, Johann J., et al.
Publicado: (2016)

Clinically relevant glioblastoma patient-derived xenograft models to guide drug development and identify molecular signatures
por: Alcaniz, Joshua, et al.
Publicado: (2023)

Preclinical Evaluation of a Companion Diagnostic Radiopharmaceutical, [(18)F]PSMA-1007, in a Subcutaneous Prostate Cancer Xenograft Mouse Model
por: Kim, Su Bin, et al.
Publicado: (2022)

Patient-derived xenografts as preclinical neuroblastoma models
por: Braekeveldt, Noémie, et al.
Publicado: (2017)

SDF1 Polymorphisms Influence Outcome in Patients with Symptomatic Cardiovascular Disease
por: Rath, Dominik, et al.
Publicado: (2016)

Circular Abscess Formation of the Inner Preputial Leaf as a Complication of a Penile Mondor's Disease: The First Case Report
por: Wendler, Johann Jakob, et al.
Publicado: (2014)

New aspects in shear-wave elastography of prostate cancer
por: Porsch, Markus, et al.
Publicado: (2015)

A New Treatment Landscape for RCC: Association of the Human Microbiome with Improved Outcomes in RCC
por: Piao, Xuan-Mei, et al.
Publicado: (2023)

Molecular subtypes and prognosis in RCC
por: Beuselinck, Benoit, et al.
Publicado: (2015)

Open Surgery for Localized RCC
por: Vander Eeckt, Kathy, et al.
Publicado: (2007)

Urine Metabolomics for Renal Cell Carcinoma (RCC) Prediction: Tryptophan Metabolism as an Important Pathway in RCC
por: Liu, Xiaoyan, et al.
Publicado: (2019)

Systemic therapy in metastatic renal cell carcinoma
por: Bedke, Jens, et al.
Publicado: (2016)

Tumour response in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors – assessment of intra-tumour heterogeneity
por: Stühler, Viktoria, et al.
Publicado: (2016)

Small renal carcinoma: the “when” and “how” of operation, active surveillance, and ablation
por: Wendler, Jakob Johann, et al.
Publicado: (2018)

Curcumin-Artemisinin Coamorphous Solid: Xenograft Model Preclinical Study
por: Mannava, M. K. Chaitanya, et al.
Publicado: (2018)

PATIENT-DERIVED XENOGRAFTS AS A PRECLINICAL MODEL FOR BONE SARCOMAS
por: MEOHAS, WALTER, et al.
Publicado: (2018)

Generation of Glioblastoma Patient-Derived Intracranial Xenografts for Preclinical Studies
por: Kerstetter-Fogle, Amber E., et al.
Publicado: (2020)

Proton Pump Inhibitors Inhibit Metformin Uptake by Organic Cation Transporters (OCTs)
por: Nies, Anne T., et al.
Publicado: (2011)

Fast lightweight accurate xenograft sorting
por: Zentgraf, Jens, et al.
Publicado: (2021)

Untangling ccRCC prognosis with SLINKY
por: Reinfeld, Bradley I., et al.
Publicado: (2017)

The Multifaceted Roles of RCC1 in Tumorigenesis
por: Ren, Xuanqi, et al.
Publicado: (2020)

Impact of hormonal therapy on the detection of promoter hypermethylation of the detoxifying glutathione-S-transferase P1 gene (GSTP1) in prostate cancer
por: Kollermann, Jens, et al.
Publicado: (2006)

Risk of infections in renal cell carcinoma (RCC) and non-RCC patients treated with mammalian target of rapamycin inhibitors
por: Kaymakcalan, M D, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1f2kh03hatmo951p1klaaps0j1